Ascendis Pharma A (ASND) Other financing activities (2021 - 2026)
Ascendis Pharma A's (ASND) quarterly Other financing activities came in at -$43.1 million in Q1 2026, down 127.45% year-on-year from $157.1 million in Q1 2025, and up 90.52% quarter-over-quarter from -$454.8 million in Q3 2025.
Ascendis Pharma A (ASND) Other financing activities (2021 - 2026) Analysis & Trends
Ascendis Pharma A has disclosed Other financing activities across 6 years of filings, most recently posting -$43.1 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ascendis Pharma A | 2.75 Bn | 2.08 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.12 Mn |
| Mar 31, 2026 | -43.12 Mn |
| Sep 30, 2025 | -454.79 Mn |
| Sep 30, 2025 | -454.79 Mn |
| Jun 30, 2025 | -10.17 Mn |
| Jun 30, 2025 | -10.17 Mn |
| Mar 31, 2025 | -18.96 Mn |
| Mar 31, 2025 | -18.96 Mn |
| Sep 30, 2024 | 469.90 Mn |
| Sep 30, 2024 | 469.90 Mn |
| Jun 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | -2.64 Mn |
| Mar 31, 2024 | 20.01 Mn |
| Mar 31, 2024 | 20.01 Mn |
| Sep 30, 2023 | 586.60 Mn |
| Sep 30, 2023 | 586.60 Mn |
| Jun 30, 2023 | -80,580.41 |
| Jun 30, 2023 | -80,580.41 |
| Mar 31, 2023 | -427.66 Mn |
| Mar 31, 2023 | -427.66 Mn |